Jacquelyn L Sumer - Net Worth and Insider Trading
Jacquelyn L Sumer Net Worth
The estimated net worth of Jacquelyn L Sumer is at least $693,554 dollars as of 2024-11-05. Jacquelyn L Sumer is the Chief Legal Officer of Cullinan Therapeutics Inc and owns about 44,133 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $693,550. Jacquelyn L Sumer is also the CHIEF LEGAL & COMPLIANCE OFF of Genocea Biosciences Inc and owns about 43,000 shares of Genocea Biosciences Inc (GNCAQ) stock worth over $4. Details can be seen in Jacquelyn L Sumer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jacquelyn L Sumer has not made any transactions after 2023-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jacquelyn L Sumer
Jacquelyn L Sumer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jacquelyn L Sumer owns 3 companies in total, including Genocea Biosciences Inc (GNCAQ) , Cullinan Therapeutics Inc (CGEM) , and Genocea Biosciences Inc (GGNNQ) .
Click here to see the complete history of Jacquelyn L Sumer’s form 4 insider trades.
Insider Ownership Summary of Jacquelyn L Sumer
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GNCAQ | Genocea Biosciences Inc | 2022-06-01 | CHIEF LEGAL & COMPLIANCE OFF |
CGEM | Cullinan Therapeutics Inc | 2023-12-21 | Chief Legal Officer |
GGNNQ | Genocea Biosciences Inc | 2021-02-22 | CHIEF LEGAL & COMPLIANCE OFF |
Jacquelyn L Sumer Latest Holdings Summary
Jacquelyn L Sumer currently owns a total of 2 stocks. Among these stocks, Jacquelyn L Sumer owns 44,133 shares of Cullinan Therapeutics Inc (CGEM) as of December 21, 2023, with a value of $693,550 and a weighting of 100%. Jacquelyn L Sumer also owns 43,000 shares of Genocea Biosciences Inc (GNCAQ) as of June 1, 2022, with a value of $4 and a weighting of 0%.
Latest Holdings of Jacquelyn L Sumer
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CGEM | Cullinan Therapeutics Inc | 2023-12-21 | 44,133 | 15.72 | 693,550 |
GNCAQ | Genocea Biosciences Inc | 2022-06-01 | 43,000 | 0.00 | 4 |
Holding Weightings of Jacquelyn L Sumer
Jacquelyn L Sumer Form 4 Trading Tracker
According to the SEC Form 4 filings, Jacquelyn L Sumer has made a total of 6 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Cullinan Therapeutics Inc is the sale of 1,400 shares on December 21, 2023, which brought Jacquelyn L Sumer around $11,900.
According to the SEC Form 4 filings, Jacquelyn L Sumer has made a total of 1 transactions in Genocea Biosciences Inc (GNCAQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Genocea Biosciences Inc is the sale of 2,500 shares on June 1, 2022, which brought Jacquelyn L Sumer around $150.
Insider Trading History of Jacquelyn L Sumer
- 1
Jacquelyn L Sumer Trading Performance
Jacquelyn L Sumer Ownership Network
Ownership Network List of Jacquelyn L Sumer
Ownership Network Relation of Jacquelyn L Sumer
Jacquelyn L Sumer Owned Company Details
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Jacquelyn L Sumer is the CHIEF LEGAL & COMPLIANCE OFF of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include director & President and CEO William D Clark , CHIEF FINANCIAL OFFICER Diantha Duvall , and 10 percent owner New Enterprise Associates 16, L.p. .
Genocea Biosciences Inc (GNCAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
Jacquelyn L Sumer Mailing Address
Above is the net worth, insider trading, and ownership report for Jacquelyn L Sumer. You might contact Jacquelyn L Sumer via mailing address: C/o Genocea Biosciences, Inc., 100 Acorn Park Drive 5th Floor, Cambridge Ma 02140.